A promising experimental compound developed by researchers at ETH Zurich could offer a new way to slow the progression of Alzheimer’s disease. In studies involving mice, the treatment reduced nerve cell loss, helped the animals live longer, and…
Continue Reading
News Source: www.sciencedaily.com

Leave a Reply